LYFCX Holdings List

No.	Symbol	Name	% Weight	Shares
1	GILD	Gilead Sciences, Inc.	7.87%	24,729
2	VRTX	Vertex Pharmaceuticals Incorporated	5.95%	5,299
3	AZN	AstraZeneca PLC	5.31%	24,140
4	INSM	Insmed Incorporated	4.13%	10,010
5	IONS	Ionis Pharmaceuticals, Inc.	3.95%	21,049
6	INCY	Incyte Corporation	3.72%	15,308
7	FXFXX	First American Treasury Obligations Fund	3.44%	1,198,844
8	ARGX	argenx SE	3.43%	1,619
9	NBIX	Neurocrine Biosciences, Inc.	3.38%	8,390
10	VRNA	Verona Pharma PLC	2.93%	9,568
11	AXSM	Axsome Therapeutics, Inc.	2.41%	6,918
12	ABBV	AbbVie Inc.	2.25%	3,385
13	ROIV	Roivant Sciences Ltd.	2.22%	51,224
14	ASND	Ascendis Pharma A/S	2.10%	3,680
15	AMGN	Amgen Inc.	2.03%	2,503
16	ALNY	Alnylam Pharmaceuticals, Inc.	1.93%	1,472
17	AVDL	Avadel Pharmaceuticals plc	1.88%	42,833
18	KRYS	Krystal Biotech, Inc.	1.86%	3,680
19	PTGX	Protagonist Therapeutics, Inc.	1.85%	9,715
20	BNTX	BioNTech SE	1.71%	6,035
21	RYTM	Rhythm Pharmaceuticals, Inc.	1.66%	5,733
22	BIIB	Biogen Inc.	1.66%	4,121
23	SNY	Sanofi	1.51%	11,123
24	JAZZ	Jazz Pharmaceuticals plc	1.45%	3,830
25	CPRX	Catalyst Pharmaceuticals, Inc.	1.41%	25,023

Showing 25 of 65 holdings

Subscribe to see the full list

As of Sep 30, 2025

Asset Allocation

Asset Class	% Weight
Stocks	97.97%
Cash	2.03%